|
|
Other links at Articles > Cardiology |
| 5. |
Spotlight on HDL-raising Therapies: Insights From the Torcetrapib Trials
|
|
|
A large trial of a medication designed to raise HDL was stopped early because of a higher risk for death among subjects receiving active treatment. However, HDL-raising therapy may still have an important role in the prevention or management of cardiovascular disease. The current article reviews these treatments. Nature Clinical Practice Cardiovascular Medicine
|
|
|